about
Overcoming drug efflux-based multidrug resistance in cancer with nanotechnologyEpigenetic reduction of DNA repair in progression to gastrointestinal cancerAccurate DNA fragment sizing by capillary electrophoresis with laser-induced fluorescence array for detection of sequence specificity of DNA damageAssociation between polymorphisms in DNA repair genes and survival of non-smoking female patients with lung adenocarcinoma.Protection of p53 wild type cells from taxol by nutlin-3 in the combined lung cancer treatment.MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer.Association between polymorphisms in XRCC1 gene and clinical outcomes of patients with lung cancer: a meta-analysis.TP53 mutations in nonsmall cell lung cancerDisparate chromatin landscapes and kinetics of inactivation impact differential regulation of p53 target genesPredictive effect of XPA and XPD polymorphisms on survival of advanced NSCLC patients treated with platinum-based chemotherapy: a three-dimensional (3-D), polyacrylamide gel-based DNA microarray method.Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposideIn vitro study on apoptosis induced by strontium-89 in human breast carcinoma cell linep53-independent structure-activity relationships of 3-ring mesogenic compounds' activity as cytotoxic effects against human non-small cell lung cancer lines.Therapeutic resistance in lung cancer.Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis.Type I insulin-like growth factor receptor induces pulmonary tumorigenesis.Distal airway epithelial progenitor cells are radiosensitive to High-LET radiationScriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells.Mapping genetic alterations causing chemoresistance in cancer: identifying the roads by tracking the drivers.The role of mitochondria in the development and progression of lung cancerA reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivo.Endostatin Sensitizes p53-Deficient Non-Small Cell Lung Cancer to Genotoxic Chemotherapy by Targeting DNA-PKcs.Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer.NBM-T-BBX-OS01, Semisynthesized from Osthole, Induced G1 Growth Arrest through HDAC6 Inhibition in Lung Cancer Cells.A non-surgical method for induction of lung cancer in Wistar rats using a combination of NNK and high dietary fats.Expression of peroxisome proliferator activated receptor-gamma (PPAR-γ) in human non-small cell lung carcinoma: correlation with clinicopathological parameters, proliferation and apoptosis related molecules and patients' survival.Protection of p53 wild type cells from taxol by genistein in the combined treatment of lung cancer.Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells.Next-generation sequencing of Chinese stage IV lung cancer patients reveals an association between EGFR mutation status and survival outcome.Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.Oncogenes do not Fully Override Cell-intrinsic Traits: Pronounced Impact of the Cellular Programme.Mutation Analysis of TP53 Tumor Suppressor Gene in Colorectal Cancer in Patients from Iran (Kerman Province).Recent insights into the biological action of heavy-ion radiation.Particular gene upregulation and p53 heterogeneous expression in TP53-mutated maxillary carcinoma.Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology.Molecular Mechanisms Underlying the Inhibitory Effects of Qingzaojiufei Decoction on Tumor Growth in Lewis Lung Carcinoma.The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population.
P2860
Q26849264-DAD00710-6C2C-46EC-9D02-52348B4AF156Q28262162-1B901CFD-3A8A-4863-AB36-5B4F8C6D9EA6Q33319267-CF99AF4C-C051-4ED3-A5FA-705CD892CB5DQ33518016-27D9F663-96FD-40CC-8407-8AD0AA299A0DQ33533630-EAB874D2-E179-418F-BA57-D5225C52EC8FQ33554403-0C16FB1D-C430-4084-A334-058FC566B5C8Q34160411-265F5089-4483-4D8C-A088-54FB180EDABFQ34559185-E543AB5E-A750-4EF9-BFC2-231E3A169CA6Q34618921-A84E62EB-0522-4DEC-9A7D-072A6D6E909DQ34686858-C728F19F-C86F-4C23-9359-DDB47638BBCDQ34994818-1EC7FA90-5C39-48A2-805A-CA8BE681F538Q35049703-5E4C5D41-D8FF-44E1-BF07-D2880CA2EC22Q36085351-174E4F76-A424-4AD0-A8D2-C98B15168BDCQ36609767-1FF698CD-BE1E-4F1B-8CC2-945EFD6BA68FQ36772120-33DC03DD-8B12-4814-AC37-636242A24480Q37229930-FD6F5AE2-5F14-4A48-9289-65BC284DABEFQ37277915-98E0D854-B95F-421B-AF7D-003E2992A6B9Q37687726-2D77CEF1-1F0B-4EF0-A502-C8493AF56DD3Q38087850-EA5326E5-C606-415F-8862-26647CAD92BAQ38201044-2EE99FD0-94A3-4B65-AB03-3761BF232322Q38411451-9BCDE01C-18BB-4139-B662-B56F31EBEBA6Q38644204-CDA5611C-FF3C-4C15-9CD7-3D35E65049E7Q38845614-F38D74CD-733A-4041-AE29-7452C8569E4EQ38878493-30E41626-22F4-4867-954E-5A958742FA58Q39486252-E16D9B81-2AAF-4B41-86E6-474199A561AFQ39639581-EA062E38-8390-4CD8-AE29-EEB0F30FEF68Q39675368-73B0DA04-5376-4484-B79B-00DCCC49D893Q39685601-490DE613-FE0F-4219-B618-88001DD3C26EQ39739208-22F5D14C-30C1-4126-A4C1-9CC51047BA53Q39925586-900233B8-FA2C-46C0-AF44-FDEF030E20CBQ40236002-EADE05E9-C08D-4739-8CDE-56362F3B43C8Q40236612-17BDC57D-3F2B-462D-BE70-FE24B9260A00Q40291299-AF47B141-DA99-4FFF-B679-7FC91D514516Q42575797-A2A5463F-B765-4609-9D06-45FABB486940Q43236627-5113EDBA-2CAF-4581-90F0-3BA2C2F29AA5Q46328892-77052A58-6957-4C92-989C-E46DBD19ABDEQ47135856-BAD04350-AD06-4DB3-9B7E-23449443B293Q48536576-A8164A96-0097-4625-A0DB-ED522FBDD5BAQ50943660-87D032A9-70AC-4484-B6F0-4E7075CA0EC5Q51161501-4D7D46B5-6023-46CB-9775-F78AB2BF8FCD
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The role of p53 in treatment responses of lung cancer
@ast
The role of p53 in treatment responses of lung cancer
@en
The role of p53 in treatment responses of lung cancer
@nl
type
label
The role of p53 in treatment responses of lung cancer
@ast
The role of p53 in treatment responses of lung cancer
@en
The role of p53 in treatment responses of lung cancer
@nl
prefLabel
The role of p53 in treatment responses of lung cancer
@ast
The role of p53 in treatment responses of lung cancer
@en
The role of p53 in treatment responses of lung cancer
@nl
P2093
P3181
P1476
The role of p53 in treatment responses of lung cancer
@en
P2093
Kristina Viktorsson
Luigi De Petris
Rolf Lewensohn
P304
P3181
P356
10.1016/J.BBRC.2005.03.192
P407
P577
2005-06-10T00:00:00Z